Permetro System: Solving Your BE and IVIVC Needs
ARLI Logan Instruments sets its sights on revolutionizing the world of bioequivalence (BE) and in-vitro and in-vivo correlation (IVIVC) studies with the Permetro system. With patents and prototypes already in the works, CEO Luke Lee stated, “This system brings together both the decades of expertise Logan has with dissolution apparatuses and the crucial aspect of proving bioequivalence in the pharmaceutical industry.” The entire Logan team is elated for the impact this state of the art instrument can make in labs around the world.
The purpose of the Permetro system is to mimic permeation rates inside the gastrointestinal (GI) tract while showing both bioequivalence and IVIVC. The system collects samples incrementally and cumulatively in parallel. Logan is bringing its expertise together in one instrument, so scientists can collect data from both dissolution and permeation tests while only needing to drop a tablet into a single dissolution bath.
Logan quickly capitalized on this new innovation by attending a small, but very relevant seminar in Rockville, MD for Scientists Advancing Affordable Medicines (SAAM) in the April 2019. Many current customers and potential new ones were there discussing topics where the Permetro System proved very intriguing. The system is expected to be released in June.
All in One...All Online
Logan is bringing its dissolution and diffusion cell systems online for an all-in-one system for both HPLC and UV analysis. The end user will be able to drop a tablet into a vessel or put their formulation on a membrane and hit the “RUN” button on the system controller, and in a desired amount of time, see results of the online analysis in the CFR 21 Part 11 compliant software. This online capability is something the industry has been seeking for years.
Logan closed out Q1 with a booth at Pittcon 2019 in Philadelphia, where it displayed their new online capabilities while meeting with distributors and vendors from around the US and the world.
Logan will be exhibiting at the Transdermal and Intradermal conference in September in Boston, the Rutgers’ Center for Dermal Research annual meeting in October in Iselin, NJ, and the AAPS conference in November in San Antonio.
Please reach out for more information on these systems: email@example.com